https://www.avancebio.com/tonometers-premarket-notification-510k-submissions-guidance-for-industry-and-fda-staff/ 2026-08-05T19:06:56+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/defining-durations-of-use-for-certain-medically-important-antimicrobial-drugs-for-food-producing-animals/ 2026-08-05T19:06:57+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/delayed-graft-function-in-kidney-transplantation-developing-drugs-for-prevention-guidance-for-industry/ 2026-08-05T19:06:57+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/labeling-for-human-prescription-drug-and-biological-products-implementing-the-plr-content-and-format-requirements/ 2026-08-05T19:06:57+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/e2br3-the-electronic-transmission-of-individual-case-safety-reports-implementation-guide-appendix-to-the-implementation-guide-backwards-and-forwards-compatibility/ 2026-08-05T19:06:58+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/microbiological-data-for-systemic-antibacterial-drug-products-development-analysis-and-presentation/ 2026-08-05T19:06:58+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/residual-solvents-in-drug-products-marketed-in-the-united-states-guidance-for-industry/ 2026-08-05T19:06:58+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/principles-for-codevelopment-of-an-in-vitro-companion-diagnostic-device-with-a-therapeutic-product-draft-guidance-for-industry-and-food-and-drug-administration-staff/ 2026-08-05T19:06:59+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/specification-of-the-unique-facility-identifier-ufi-system-for-drug-establishment/ 2026-08-05T19:06:59+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/q10-pharmaceutical-quality-system/ 2026-08-05T19:06:59+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/nonbinding-feedback-after-certain-fda-inspections-of-device-establishments-guidance-for-industry-and-food-and-drug-administration-staff/ 2026-08-05T19:07:00+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/prussian-blue-drug-products-submitting-a-new-drug-application/ 2026-08-05T19:07:00+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/possible-dioxin-pcb-contamination-of-drug-and-biological-products/ 2026-08-05T19:07:00+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/human-prescription-drug-and-biological-products-labeling-for-dosing-based-on-weight-or-body-surface-area-for-ready-to-use-containers-dose-banding/ 2026-08-05T19:07:01+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/implementation-of-section-120-of-the-food-and-drug-administration-modernization-act-of-1997-advisory-committees/ 2026-08-05T19:07:01+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/considerations-for-the-development-of-dried-plasma-products-intended-for-transfusion-guidance-for-industry/ 2026-08-05T19:07:02+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/opioid-analgesic-drugs-considerations-for-benefit-risk-assessment-framework/ 2026-08-05T19:07:03+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/m11-clinical-electronic-structured-harmonised-protocol/ 2026-08-05T19:07:04+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/adverse-event-reporting-for-outsourcing-facilities-under-section-503b-of-the-federal-food-drug-and-cosmetic-act/ 2026-08-05T19:07:04+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/cvm-gfi-123-development-of-data-supporting-approval-of-nsaids-for-use-in-animals/ 2026-08-05T19:07:04+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/draft-guidance-for-industry-questions-and-answers-on-the-accredited-third-party-certification-program/ 2026-08-05T19:07:05+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/attachement-qualification-process-for-drug-development-tools-qualification-of-exacerbations-of-chronic-pulmonary-disease-tool-for-measurement-of-symptoms-of-acute-bacterial-exacerbation-of-chronic/ 2026-08-05T19:07:05+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/guidance-for-the-submission-of-premarket-notifications-for-emission-computed-tomography-devices-and-accessories-spect-and-pet-and-nuclear-tomography-systems-guidance-for-industry/ 2026-08-05T19:07:05+00:00 https://www.avancebio.com/e19-optimisation-of-safety-data-collection/ 2026-08-05T19:07:06+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/consumer-antiseptic-wash-final-rule-questions-and-answers-guidance-for-industry/ 2026-08-05T19:07:06+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/cpg-sec-690-150-labeling-and-marketing-of-dog-and-cat-food-diets-intended-to-diagnose-cure-mitigate-treat-or-prevent-diseases/ 2026-08-05T19:07:07+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/content-and-format-of-inds-for-phase-1-studies-of-drugs-including-well-characterized-therapeutic-biotechnology-derived-products-questions-and-answers-guidance-for-industry-qa/ 2026-08-05T19:07:07+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/guidance-for-industry-for-the-submission-of-chemistry-manufacturing-and-controls-information-for-a-therapeutic-recombinant-dna-derived-product-or-a-monoclonal-antibody-product-for-in-vivo-use/ 2026-08-05T19:07:07+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/preclinical-assessment-of-investigational-cellular-and-gene-therapy-products-guidance-for-industry/ 2026-08-05T19:07:08+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/bioavailability-and-bioequivalence-studies-for-nasal-aerosols-and-nasal-sprays-for-local-action/ 2026-08-05T19:07:08+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/guidance-document-for-testing-non-articulating-mechanically-locked-modular-implant-components/ 2026-08-05T19:07:08+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/cancer-clinical-trial-eligibility-criteria-available-therapy-in-non-curative-settings-guidance-for-industry/ 2026-08-05T19:07:09+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/cvm-gfi-149-vich-gl33-studies-to-evaluate-the-safety-of-residues-of-veterinary-drugs-in-human-food-general-approach-to-testing/ 2026-08-05T19:07:09+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/cvm-gfi-231-distributor-labeling-for-new-animal-drugs/ 2026-08-05T19:07:10+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/guidance-document-for-the-preparation-of-premarket-notification-510k-applications-for-exercise-equipment/ 2026-08-05T19:07:10+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/adjusting-for-covariates-in-randomized-clinical-trials-for-drugs-and-biological-products/ 2026-08-05T19:07:11+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/computer-assisted-detection-devices-applied-to-radiology-images-and-radiology-device-data-premarket-notification-510k-submissions-guidance-for-industry-and-food-and-drug-administration-staff/ 2026-08-05T19:07:15+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/cpg-sec-310-210-blood-pressure-measurement-devices-sphygmomanometers-accuracy/ 2026-08-05T19:07:15+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/assessing-adhesion-with-transdermal-and-topical-delivery-systems-for-andas-draft-guidance-for-industry/ 2026-08-05T19:07:16+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/liposome-drug-products-chemistry-manufacturing-and-controls-human-pharmacokinetics-and-bioavailability-and-labeling-documentation/ 2026-08-05T19:07:16+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/cvm-gfi-282-informed-consent-forms-for-studies-that-enroll-client-owned-companion-animals/ 2026-08-05T19:07:17+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/s6-preclinical-safety-evaluation-of-biotechnology-derived-pharmaceuticals/ 2026-08-05T19:07:17+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/good-review-management-principles-and-practices-for-new-drug-applications-and-biologics-license-applications-draft-guidance-for-industry-and-review-staff/ 2026-08-05T19:07:18+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/grandfathering-policy-for-packages-and-homogenous-cases-of-product-without-a-product-identifier/ 2026-08-05T19:07:18+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/requalification-method-for-reentry-of-donors-who-test-hepatitis-b-surface-antigen-hbsag-positive-following-a-recent-vaccination-against-hepatitis-b-virus-infection-guidance-for-industry/ 2026-08-05T19:07:18+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/general-considerations-for-animal-studies-intended-to-evaluate-medical-devices-guidance-for-industry-and-food-and-drug-administration-staff/ 2026-08-05T19:07:19+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/bladder-cancer-developing-drugs-and-biologics-for-adjuvant-treatment-guidance-for-industry/ 2026-08-05T19:07:19+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/mucopolysaccharidosis-type-iii-sanfilippo-syndrome-developing-drugs-for-treatment-guidance-for-industry-draft-guidance-for-industy/ 2026-08-05T19:07:20+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/cpg-sec-420-100-adulteration-of-drugs-under-section-501b-and-501c-of-the-act-direct-reference-seizure-authority-for-adulterated-drugs-under-section-501b/ 2026-08-05T19:07:20+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/further-testing-of-donations-that-are-reactive-on-a-licensed-donor-screening-test-for-antibodies-to-hepatitis-c-virus-guidance-for-industry/ 2026-08-05T19:07:21+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/providing-over-the-counter-monograph-submissions-in-electronic-format/ 2026-08-05T19:07:22+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/dental-composite-resin-devices-premarket-notification-510k-submissions-draft-guidance-for-industry-and-food-and-drug-administration-staff/ 2026-08-05T19:07:22+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/evaluation-of-therapeutic-equivalence/ 2026-08-05T19:07:22+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/harmonizing-compendial-standards-with-drug-application-approval-using-the-usp-pending-monograph-process-guidance-for-industry/ 2026-08-05T19:07:23+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/cvm-gfi-195-small-entities-compliance-guide-for-renderers-substances-prohibited-from-use-in-animal-food-or-feed/ 2026-08-05T19:07:23+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/guidance-for-the-content-of-premarket-notifications-for-esophageal-and-tracheal-prostheses-guidance-for-industry/ 2026-08-05T19:07:23+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/prescription-drug-user-fee-act-waivers-reductions-and-refunds-for-drug-and-biological-products-guidance-for-industry/ 2026-08-05T19:07:25+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/guidance-for-manufacturers-seeking-marketing-clearance-of-ear-nose-and-throat-endoscope-sheaths-used-as-protective-barriers-guidance-for-industry/ 2026-08-05T19:07:25+00:00 https://www.avancebio.com/cvm-gfi-271-reporting-and-mitigating-animal-drug-shortages/ 2026-08-05T19:07:26+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/denture-base-resins-performance-criteria-for-safety-and-performance-based-pathway-guidance-for-industry-and-food-and-drug-administration-staff/ 2026-08-05T19:07:26+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/labeling-for-biosimilar-and-interchangeable-biosimilar-products/ 2026-08-05T19:07:27+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/cvm-gfi-241-small-entity-compliance-guide-what-you-need-to-know-about-the-fda-regulation-current-good-manufacturing-practice-hazard-analysis-and-risk-based-preventive-controls-for-food-f/ 2026-08-05T19:07:27+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/monoclonal-antibodies-streamlined-nonclinical-safety-studies-draft-guidance-for-industry/ 2026-08-05T19:07:28+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/risk-management-plans-to-mitigate-the-potential-for-drug-shortages/ 2026-08-05T19:07:28+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/s2b-genotoxicity-a-standard-battery-for-genotoxicity-testing-of-pharmaceuticals/ 2026-08-05T19:07:28+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png https://www.avancebio.com/qualified-infectious-disease-product-designation-questions-and-answers-guidance-for-industy/ 2026-08-05T19:07:29+00:00 https://www.avancebio.com/wp-content/uploads/2018/06/pdf.png